Cancer Diagnoses Lag After Screenings Fall During Pandemic

Although Americans are getting back to a normal way of life, they still appear to be avoiding the healthcare system, new research finds.

By Shawana Alleyne-Morris

Screenings for a variety of common cancers have not returned to pre-pandemic levels, potentially leading to diagnoses later in the course of the disease when it may be more difficult to treat successfully, U.S. data suggest.

In 2020 – the first year of the pandemic – average rates of screening for breast cancer fell by 40%, for cervical cancer by 36%, and for colorectal cancer by 45%, compared to the three previous years, according to an analysis released November 17 of medical claims data from 306 million adults.

Diagnoses of breast, cervical and colorectal cancers dropped by roughly 6% to 7% between 2019 and 2020 and by an additional 5% to 6% between 2020 and 2021, the researchers also found.

The decrease in diagnoses “does not mean these cancers are suddenly less common,” said study leader Allison Oakes of data analytics company Trilliant Health in Brentwood, Tennessee. “Rather, it means there are people with cancer who are going to be diagnosed at a later, more severe stage of the disease.”

By the end of 2021, screening rates had rebounded but were still below pre-pandemic levels, researchers reported in JAMA Oncology.

Ongoing analysis of 2022 data suggests screening rates in 2022 are unlikely to have improved dramatically, Oakes said.

“We do not see significant changes in behavior when looking quarter-over-quarter,” she added.

The issue appears to go beyond cancer testing, the study found.

Additional Reading: The Likelihood of Developing Cancer Increases Greatly with Age

Healthcare utilization for non-COVID, non-mental-health issues in the first quarter of 2022 was 6.2% lower than in the first quarter of 2019, Oakes said.

“Not only are people missing their annual cancer screenings, but they are using less primary care,” Oakes said.

“While Americans appear to be getting back to normal everyday life, whether in-office work or leisure travel, many of them are still avoiding the healthcare system.”

This article was provided by Reuters.

Latest news

SEC Charges Investment Advisors for Overstating Use of AI

The two firms will pay $400,000 in total civil penalties for false marketing and the SEC is on the lookout for more offenders.

JPMorgan Fined $348 Million for Lapses in Trade Monitoring

The bank had failed to account for “billions of instances of trading activity” on as many as 30 different platforms, regulators said.

Top-Heavy Market Doesn’t Mean Steep Correction. Here’s Why

It's been 100 years since the market has been this top heavy, giving rise to understandable fears. History suggest those fears are overdone.

Judge: Minority-Business Agency Can’t Consider Race

A federal judge in Texas has barred a government agency from using race to reject entrepreneurs looking for assistance.

IRS Alert: Weight-Loss Food Is Typically Not a Medical Expense

Companies are falsely claiming that FSAs and HSAs cover or reimburse general health and wellness expenses.

Annuities Continue March Upward

Annuities saw an impressive boom in 2023, with sales reaching a new all-time high, LIMRA announced.